CD11b also known as ITAM (or) Integrin alpha-M or MAC-1 alpha subunit or CR3 alpha chain is member of the integrin alpha chain family, expressed predominately in human myeloid cells, follicular dendritic cells, NK1 cells, monocytes and granulocytes. The alpha subunit of ITAM/beta-2 complex (CD11b/CD18, Mac-1), is a receptor for fibrinogen, factor X, and ICAM1. ITAM/beta-2 is implicated in adhesive interactions of monocytes, macrophages, and granulocytes. CD11b has been used as a common myeloid marker. CD11b is expressed in about 50% of acute myeloid leukemia (AML). In combination with CD117, CD11b is helpful in differentiating acute promyelocytic leukemia (CD11b negative) from recovering benign myeloid proliferation (CD11b positive, CD117 negative). In acute promyelocytic leukemia patients treated with all-trans retinoic acid or Arsenic trioxide (As2O3), CD11b is a marker for differentiating the induction of leukemia cells. CD11b is also expressed on microglia cells and involved in the development of neurodegenerative diseases.
Intended Use: IVD
Antibody Type: Monoclonal
Clone: EP45
Source: Rabbit
Tissue Type/Cancer Type: Spleen